CCL2 is reported to directly induce PC cell line proliferation and migration in prostate cancer via phosphoinositide-3-kinase (PI3K)/serine-threonine kinase (Akt) signaling activation [16]. The gene discussed is AKT1; the disease is prostate carcinoma.